Novartis trial win lifts profile of new breast cancer drug Ruby Khatun Khatun27 Aug 2018 9:30 AM ISTZURICH: Novartis's efforts to tackle an elusive gene mutation behind tough-to-treat breast cancer were rewarded, as the Swiss drugmaker said one of...
UAE based NMC Healthcare highest bidder for SevenHills hospital: Report Ruby Khatun Khatun26 Aug 2018 12:36 PM ISTMUMBAI: Several firms have been vying for acquiring SevenHills Hospital in Mumbai and according to recent media report, billionaire BR Shetty led...
Lupin gets USFDA tentative approval for generic Nudovra Ruby Khatun Khatun26 Aug 2018 11:00 AM ISTMumbai: Pharma major Lupin announced that it has received tentative approval for its Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol...
CEO’s of Novartis, WhatsApp meet Telangana Minister Ruby Khatun Khatun26 Aug 2018 10:15 AM ISTHyderabad: Two eminent corporate honchos- CEO of Whatsapp and Novartis, separately met the Telangana Minister for IT and Industries KT Rama Rao...
AstraZeneca inhaler lags GSK drug in lung disease trial Ruby Khatun Khatun26 Aug 2018 10:00 AM ISTLONDON: A new AstraZeneca inhaler for chronic lung disease has proved worse than a rival GlaxoSmithKline product in a clinical trial, a result...
USFDA approves Kala Pharma's eye pain drug Ruby Khatun Khatun26 Aug 2018 9:45 AM ISTThe U.S. Food and Drug Administration approved Kala Pharmaceuticals Inc's treatment for reducing inflammation and pain following an eye surgery.The...
Johnson and Johnson Faulty Hip Implants: Ministry asks States to determine Compensation Ruby Khatun Khatun25 Aug 2018 5:44 PM ISTThe panel set up by the health ministry had recommended a base amount of Rs 20 lakh as compensation to each patient who had received the faulty hip...
Lupin gets EIR from USFDA for Nagpur facility Ruby Khatun Khatun25 Aug 2018 11:12 AM ISTNew Delhi: Drug firm Lupin said it has received an establishment inspection report (EIR) from the US health regulator after the successful inspection...
Health startup Medcords raises Rs 2.64 crore from Naukri.com owner Ruby Khatun Khatun25 Aug 2018 10:24 AM ISTNaukri.com owner Sanjeev Bikhchandani has invested Rs Rs 2.64 crore in digital medical platform MedcordsNew Delhi: Naukri.com owner Info Edge has...
FDA approves Oxervate for neurotrophic keratitis, a rare eye disease Ruby Khatun Khatun25 Aug 2018 10:15 AM ISTThe U.S. Food and Drug Administration (FDA) approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare...
Oklahoma Medicaid tests new tactic to curb US drug costs Ruby Khatun Khatun25 Aug 2018 9:45 AM ISTLOS ANGELES: A new front in the battle over the cost of expensive medicines in the United States is opening up in Oklahoma, the first state where the...
Sunil Godhwani responsible for Fortis Group woes: Singh Brothers Issue Statement Ruby Khatun Khatun24 Aug 2018 4:36 PM ISTBloomberg has reported that Sunil Godhwani is the follower of the spiritual group, Radha Soami Satsang Beas and was appointed to lead Religare at the...
